Cell Cycle Dependent Mechanisms of Renal Hypertrophy
肾肥大的细胞周期依赖性机制
基本信息
- 批准号:6623538
- 负责人:
- 金额:$ 20.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-15 至 2007-01-31
- 项目状态:已结题
- 来源:
- 关键词:AP1 protein cell cycle cell growth regulation cyclin dependent kinase diabetic nephropathy gel mobility shift assay gene expression genetic regulation genetically modified animals glomerulosclerosis glucose immunoprecipitation insulin dependent diabetes mellitus kidney cell kidney hypertrophy laboratory mouse mesangium phosphorylation protooncogene retinoblastoma protein site directed mutagenesis western blottings
项目摘要
DESCRIPTION (Provided by applicant): Early in diabetic nephropathy glomerular
mesangium and renal tubules hypertrophy. Mesangial hypertrophy is an important,
perhaps reversible, step preceding glomeruloscierosis and overt nephropathy.
Using unique transgenic mice overexpressing retinoblastoma protein (Rb) and
mesangial cells expressing Rb from a tetracycline-confrollable promoter system,
we have discovered that renal and glomerular mesangial cell hypertrophy occur
with both diabetes mellitus and with over expression of hypophosphorylated Rb.
Preliminary data has shown that when Rh is over expressed, neither kidneys nor
mesangial cells hypertrophy further in diabetic conditions. Our hypothesis to
explain these observations is that excess glucose results in specific,
cyclin-dependent phosphorylation of Rb protein during early Gi phase, and that
Rb is involved distally in a pathway of glomerular mesangial cell hypertrophy.
To test this hypothesis, three Specific Aims are proposed: (1) Determine
whether renal and glomerular hypertrophy caused by diabetes mellitus in vivo
and mesangial cell hypertrophy caused by high glucose concentrations ex vivo
are dependent on activation of specific C1 phase cyclin-cdk complexes and
specific phosphorylations of Rb protein. (2) Determine how high glucose
regulates cdk4-cyclin Dl activity and Rb phosphorylation in mesangial cells by
examining patterns of gene regulation including transcription of the cyclin D1
gene itself and of events controlled by relevant transcription factors
including AP-1. (3) Test the requirement for Cl cyclin dependent kinase
activation and specific cdk4-dependent phosphorylations of Rb protein for
diabetic renal hypertrophy in vivo and mesangial cell hypertrophy in culture.
Transgenic mice with strategic phosphorylation sites in Rb inactivated by
site-directed mutagenesis will be generated and the effects of type 1 diabetes
mellitus will be examined in them. Primary mesangial cells will also be
cultured from the mice and more detailed studies on hypertrophy and GI cell
cycle regulation by cdks and Rb conducted in vitro.
描述(申请人提供):早期糖尿病肾病肾小球
系膜和肾小管肥大。系膜肥大是一种重要的、
可能是可逆的,先于肾小球硬化和临床肾病。
使用过表达视网膜母细胞瘤蛋白(Rb)和
系膜细胞表达来自四环素-可控制启动子系统的Rb,
我们发现肾和肾小球系膜细胞肥大。
既有糖尿病,又有低磷酸化Rb的过度表达。
初步数据显示,当Rh过度表达时,无论是肾脏还是
糖尿病时系膜细胞进一步肥大。我们的假设是
解释这些观察结果的原因是过量的葡萄糖会导致特定的,
依赖细胞周期蛋白的Rb蛋白在胃肠道早期的磷酸化
Rb在远端参与了肾小球系膜细胞肥大的途径。
为了验证这一假设,提出了三个具体目标:(1)确定
糖尿病是否导致体内肾脏和肾小球肥大
体外高糖致系膜细胞肥大
依赖于特定的C1期细胞周期蛋白-cdk复合体的激活和
Rb蛋白的特异性磷酸化。(2)确定血糖有多高
人肾小球系膜细胞CDK4-Cyclin D1活性和Rb磷酸化的调节
检测基因调控的模式,包括细胞周期蛋白D1的转录
基因本身和由相关转录因子控制的事件
包括AP-1。(3)检测对氯化细胞周期蛋白依赖性激酶的要求
Rb蛋白的激活及其依赖于CDK4的特异性磷酸化
体内糖尿病肾肥大和体外培养的系膜细胞肥大。
Rb策略磷酸化位点的转基因小鼠被灭活
将产生定点突变和1型糖尿病的影响
将在他们身上检查糖尿病。原代系膜细胞也将
小鼠的培养及对肥大和胃肠道细胞更详细的研究
CDKs和Rb在体外进行的周期调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL J RILEY其他文献
DANIEL J RILEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL J RILEY', 18)}}的其他基金
Nek1 Protein Kinase and Polycystic Kidney Disease
Nek1 蛋白激酶与多囊肾病
- 批准号:
7508961 - 财政年份:2007
- 资助金额:
$ 20.17万 - 项目类别:
Cell Cycle Dependent Mechanisms of Renal Hypertrophy
肾肥大的细胞周期依赖性机制
- 批准号:
7017009 - 财政年份:2002
- 资助金额:
$ 20.17万 - 项目类别:
Cell Cycle Dependent Mechanisms of Renal Hypertrophy
肾肥大的细胞周期依赖性机制
- 批准号:
6729104 - 财政年份:2002
- 资助金额:
$ 20.17万 - 项目类别:
Cell Cycle Dependent Mechanisms of Renal Hypertrophy
肾肥大的细胞周期依赖性机制
- 批准号:
6466738 - 财政年份:2002
- 资助金额:
$ 20.17万 - 项目类别:
Cell Cycle Dependent Mechanisms of Renal Hypertrophy
肾肥大的细胞周期依赖性机制
- 批准号:
6845408 - 财政年份:2002
- 资助金额:
$ 20.17万 - 项目类别:
相似海外基金
Investigating ubiquitination-regulated cell cycle events underpinning malaria transmission
研究泛素化调节的细胞周期事件支撑疟疾传播
- 批准号:
MR/Y013174/1 - 财政年份:2024
- 资助金额:
$ 20.17万 - 项目类别:
Research Grant
Investigating cell cycle vulnerabilities in TP53 mutant cancers
研究 TP53 突变癌症的细胞周期脆弱性
- 批准号:
MR/Y01264X/1 - 财政年份:2024
- 资助金额:
$ 20.17万 - 项目类别:
Research Grant
Conference: FASEB Yeast Chromosome and Cell Cycle Conference 2024
会议:2024 年 FASEB 酵母染色体和细胞周期会议
- 批准号:
2403471 - 财政年份:2024
- 资助金额:
$ 20.17万 - 项目类别:
Standard Grant
MRC TS Award: Regulation of neutrophil functions by cell cycle proteins
MRC TS 奖:细胞周期蛋白调节中性粒细胞功能
- 批准号:
MR/X023087/1 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Fellowship
Developmental regulation of the cell cycle machinery
细胞周期机制的发育调控
- 批准号:
10714634 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication
不完全复制后结构变异形成的细胞周期时间和分子机制
- 批准号:
10656861 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Cell cycle control of cell polarity and fate in epidermal morphogenesis
表皮形态发生中细胞极性和命运的细胞周期控制
- 批准号:
10608036 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Cell cycle-dependent dynein adaptor switching
细胞周期依赖性动力蛋白适配器转换
- 批准号:
23KF0285 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Regulation of Cell Cycle progression by the nuclear envelope
核膜对细胞周期进程的调节
- 批准号:
10659597 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:














{{item.name}}会员




